Ilhan Lim - Search Results

Year	Number of Results
2004	2
2007	1
2010	2
2011	1
2012	4
2013	8
2014	8
2015	3
2016	5
2017	1
2018	5
2019	7
2020	8
2021	11
2022	5
2023	5
2024	2

1

PET/MRI and Novel Targets for Breast Cancer.

Chung HW, Park KS, Lim I, Noh WC, Yoo YB, Nam SE, So Y, Lee EJ. Chung HW, et al. Among authors: lim i. Biomedicines. 2024 Jan 12;12(1):172. doi: 10.3390/biomedicines12010172. Biomedicines. 2024. PMID: 38255277 Free PMC article. Review.

2

Positron emission tomography (PET) radiotracers for prostate cancer imaging.

Walker SM, Lim I, Lindenberg L, Mena E, Choyke PL, Turkbey B. Walker SM, et al. Among authors: lim i. Abdom Radiol (NY). 2020 Jul;45(7):2165-2175. doi: 10.1007/s00261-020-02427-4. Abdom Radiol (NY). 2020. PMID: 32047993 Review.

3

Incidental 18F-Florapronol Uptake in Meningioma.

Lee I, Kong JS, Youn SM, Lim I, Ha JH. Lee I, et al. Among authors: lim i. Clin Nucl Med. 2021 Aug 1;46(8):e431-e432. doi: 10.1097/RLU.0000000000003565. Clin Nucl Med. 2021. PMID: 33661207

4

The Feasibility of ⁶⁴Cu-PSMA I&T PET for Prostate Cancer.

Lee CH, Lim I, Woo SK, Kim KI, Lee KC, Song K, Choi CW, Lim SM. Lee CH, et al. Among authors: lim i. Cancer Biother Radiopharm. 2022 Aug;37(6):417-423. doi: 10.1089/cbr.2020.4189. Epub 2021 Jan 12. Cancer Biother Radiopharm. 2022. PMID: 33434438

5

64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression.

Lee I, Lim I, Lee KC, Kang HJ, Lim SM. Lee I, et al. Among authors: lim i. Clin Nucl Med. 2023 Feb 1;48(2):e82-e83. doi: 10.1097/RLU.0000000000004378. Epub 2022 Sep 21. Clin Nucl Med. 2023. PMID: 36127796

6

Combination of ¹³¹I-trastuzumab and lanatoside C enhanced therapeutic efficacy in HER2 positive tumor model.

Vinod N, Kim JH, Choi S, Lim I. Vinod N, et al. Among authors: lim i. Sci Rep. 2021 Jun 18;11(1):12871. doi: 10.1038/s41598-021-92460-0. Sci Rep. 2021. PMID: 34145369 Free PMC article.

7

The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy.

Choi JH, Lim I, Byun BH, Kim BI, Choi CW, Kang HJ, Shin DY, Lim SM. Choi JH, et al. Among authors: lim i. PLoS One. 2022 Sep 26;17(9):e0273839. doi: 10.1371/journal.pone.0273839. eCollection 2022. PLoS One. 2022. PMID: 36156599 Free PMC article.

8

Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of ²²⁵Ac-DOTA-rituximab using ⁶⁴Cu-DOTA-rituximab.

Lee CH, Lim I, Woo SK, Kim W, Kim KI, Lee KC, Song K, Lim SM. Lee CH, et al. Among authors: lim i. Ann Nucl Med. 2021 May;35(5):639-647. doi: 10.1007/s12149-021-01607-6. Epub 2021 Apr 3. Ann Nucl Med. 2021. PMID: 33811601

9

A Comparison of ¹⁸F-DCFPyL, ¹⁸F-NaF, and ¹⁸F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer.

Fourquet A, Rosenberg A, Mena E, Shih JJ, Turkbey B, Blain M, Bergvall E, Lin F, Adler S, Lim I, Madan RA, Karzai F, Gulley JL, Dahut WL, Wood BJ, Chang R, Levy E, Choyke PL, Lindenberg L. Fourquet A, et al. Among authors: lim i. J Nucl Med. 2022 May;63(5):735-741. doi: 10.2967/jnumed.121.262371. Epub 2021 Sep 2. J Nucl Med. 2022. PMID: 34475237 Free article.

10

Deep Learning-Based Delayed PET Image Synthesis from Corresponding Early Scanned PET for Dosimetry Uptake Estimation.

Kim K, Byun BH, Lim I, Lim SM, Woo SK. Kim K, et al. Among authors: lim i. Diagnostics (Basel). 2023 Sep 25;13(19):3045. doi: 10.3390/diagnostics13193045. Diagnostics (Basel). 2023. PMID: 37835788 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year